26.11.2012 Views

Annual Report 2000 - Clariant

Annual Report 2000 - Clariant

Annual Report 2000 - Clariant

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Growth was driven by two<br />

factors: for one thing, sales<br />

momentum picked up again as<br />

volumes increased; for another,<br />

expansion was driven by<br />

acquisitions along with<br />

favorable exchange rates.<br />

With its strong position in electronic<br />

materials and fine<br />

chemicals, <strong>Clariant</strong> is now well<br />

placed in two future-oriented<br />

markets with considerable<br />

growth potential.<br />

A message from the Chairman<br />

Seizing change as an opportunity<br />

<strong>Clariant</strong> has had an eventful year, scoring a number of<br />

successes but also suffering some disappointments. On<br />

the one hand, with the successful takeover of the British<br />

company BTP we reached a strategic milestone in the<br />

promising area of fine chemicals; this step has made us<br />

into a leading partner for the pharmaceutical and agrochemical<br />

industries. On the other hand, though, the price<br />

of our share plummeted as the stock market turned its<br />

back on traditional industrial stocks. Fortunately, our<br />

employees have not allowed themselves to be distracted<br />

by the vagaries of the market and have persistently<br />

focused on strengthening the company's performance<br />

and growth potential. I would like to take this opportunity<br />

to thank all of you for this achievement.<br />

Divisional sales in <strong>2000</strong> climbed by +16% from CHF<br />

9,158 million to CHF 10,583 million. This growth was<br />

driven by two factors: for one thing, sales momentum<br />

picked up again as sales volumes increased; for another,<br />

expansion was driven by acquisitions along with favorable<br />

exchange rates. Operating profit before goodwill<br />

amortization rose CHF 53 million to CHF 1,135 million<br />

from the year-back figure of CHF 1,082 million. Adjusted<br />

for one-off revenues in the previous year, the improvement<br />

comes to CHF 118 million or +12%. The steep<br />

increase in the price of raw materials (the bill swelled by<br />

some CHF 200 million) could only be partially offset by<br />

passing on higher prices to customers, and then only<br />

with a time lag. <strong>Clariant</strong> met this reduction in earnings<br />

head on by initiating measures to cut costs and increase<br />

efficiency, and the impact of these moves will be felt in<br />

future too. Net income after minorities fell by –14% from<br />

CHF 587 million to CHF 505 million, owing in particular to<br />

additional acquisition-related goodwill amortization and<br />

higher financing costs connected with the takeover of<br />

BTP. Earnings per share accordingly declined from CHF<br />

41.13 to CHF 34.14. However, earnings per share before<br />

goodwill amortization (“cash earnings”) increased from<br />

CHF 42.39 to CHF 42.61. Given the positive outlook for<br />

the future, the Board of Directors will propose to the<br />

company's shareholders to raise the dividend by +10%<br />

from CHF 10 to CHF 11 per share.<br />

The stock market turned its back on the specialty<br />

chemical sector, pushing down share prices for the<br />

industry as a whole and for <strong>Clariant</strong> in particular. The<br />

reasons investors gave for this trend – which we do not<br />

understand – are according to their opinion the more<br />

attractive investment opportunities to be found in other<br />

industries, the slowdown in the chemical sector and the<br />

steep rise in commodity prices. However, we were never<br />

forced to issue a profit warning because our business is<br />

broad-based and we are able to respond to business<br />

challenges swiftly. Nonetheless, over the year the share<br />

price fell to a 12-month low of CHF 461, though it did<br />

rally to finish at CHF 581.<br />

As regards strategy, we forged ahead with the implementation<br />

of the Strategic Plan that was adopted in<br />

1999. The takeover of BTP in the spring marked a major<br />

step in this direction. The product ranges, the know-how<br />

in chemical technology and the two management teams<br />

are all a perfect fit. We are confident that the pharmaceutical<br />

and agrochemical industries will increasingly<br />

turn to specialist fine chemical manufacturers for the<br />

production of their intermediates and active ingredients.<br />

With its strong position in electronic materials, <strong>Clariant</strong><br />

is now well placed in two future-oriented markets with<br />

considerable growth potential. At the same time as we<br />

expand in our strategic growth areas, we will continue to<br />

dispose of semispecialty and specialty activities this<br />

year in order to streamline our business portfolio. The<br />

areas affected are those with insufficient growth and<br />

earnings potential as well as businesses that are of little<br />

strategic interest to <strong>Clariant</strong> despite their good performance<br />

and that would flourish better in a more suitable<br />

environment.<br />

At the operational level, the strong performance by<br />

the divisions and local Group companies makes confident<br />

about the future: production plants were further<br />

optimized and adapted to meet market needs and, we<br />

are very pleased by the increased share of new and innovative<br />

products. This success, however, should not blind<br />

us to the fact that 2001 will be yet another very challenging<br />

year. The chemical industry is still in flux, and we<br />

are bound to see further changes in the environment. Our<br />

Exactly your chemistry.<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!